1. Glutamate Receptor Antagonists in the Management of Migraine

   • Kayi Chan
   • Antoinette MaassenVanDenBrink

   Leading Article 17 July 2014 Pages: 1165 - 1176

2. The Role of Atypical Antipsychotics for Treatment of Tourette’s Syndrome: An Overview

   • Cathy L. Budman

   Review Article 18 July 2014 Pages: 1177 - 1193

3. Dehydroepiandrosterone (DHEA): Hypes and Hopes

   • Krzysztof Rutkowski
   • Paweł Sowa
   • Ryszard Rutkowski

   Review Article 15 July 2014 Pages: 1195 - 1207

4. Edoxaban: An Update on the New Oral Direct Factor Xa Inhibitor

   • Henri Bounameaux
   • A. John Camm

   Review Article Open access 18 July 2014 Pages: 1209 - 1231

   

5. Nivolumab: A Review of Its Use in Patients with Malignant Melanoma

   • Emma D. Deeks

   Adis Drug Evaluation 15 July 2014 Pages: 1233 - 1239

   

6. Dolutegravir: A Review of Its Use in the Management of HIV-1 Infection in Adolescents and Adults

   • Paul L. McCormack

   Adis Drug Evaluation 09 July 2014 Pages: 1241 - 1252

   

7. Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (Gardasil^®): A Review of Its Use in the Prevention of Premalignant Anogenital Lesions, Cervical and Anal Cancers, and Genital Warts

   • Paul L. McCormack

   Adis Drug Evaluation 15 July 2014 Pages: 1253 - 1283

   

8. Ceritinib: First Global Approval

   • Sohita Dhillon
   • Madeleine Clark

   R&D Insight Report 01 July 2014 Pages: 1285 - 1291

   

9. Vedolizumab: First Global Approval

   • Raewyn M. Poole

   R&D Insight Report 02 July 2014 Pages: 1293 - 1303

10. Erratum to: Non-dopaminergic Treatments for Motor Control in Parkinson’s Disease

    • Susan H. Fox

    Erratum 11 July 2014 Pages: 1305 - 1305